MENU
+Compare
BHC
Stock ticker: NYSE
AS OF
Aug 15 closing price
Price
$8.34
Change
+$0.83 (+11.05%)
Capitalization
3.1B

BHC Bausch Health Companies Forecast, Technical & Fundamental Analysis

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets... Show more

BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BHC with price predictions
Aug 15, 2025

BHC in +16.32% Uptrend, rising for three consecutive days on August 15, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where BHC advanced for three days, in of 288 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 12, 2025. You may want to consider a long position or call options on BHC as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BHC just turned positive on August 12, 2025. Looking at past instances where BHC's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

BHC moved above its 50-day moving average on August 11, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for BHC crossed bullishly above the 50-day moving average on August 13, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BHC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BHC broke above its upper Bollinger Band on August 15, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BHC entered a downward trend on August 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (16.499). P/E Ratio (32.077) is within average values for comparable stocks, (72.127). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.761). BHC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (0.314) is also within normal values, averaging (40.137).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BHC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BHC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BHC is expected to report earnings to rise 182.50% to $1.13 per share on October 30

Bausch Health Companies BHC Stock Earnings Reports
Q3'25
Est.
$1.13
Q2'25
Beat
by $0.36
Q1'25
Missed
by $0.26
Q4'24
Beat
by $0.02
Q3'24
Missed
by $1.26
The last earnings report on July 30 showed earnings per share of 40 cents, beating the estimate of 3 cents. With 9.18M shares outstanding, the current market capitalization sits at 3.10B.
A.I.Advisor
published Dividends

BHC paid dividends on December 22, 2010

Bausch Health Companies BHC Stock Dividends
А quarterly dividend of $1.00 per share was paid with a record date of December 22, 2010, and an ex-dividend date of November 10, 2010. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
2150 Saint Elzear Boulvard West
Phone
+1 514 744-6792
Employees
20270
Web
https://www.bauschhealth.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TCIEX27.290.15
+0.55%
Nuveen International Eq Idx R6
FBBAX28.070.05
+0.18%
First Foundation Total Return A
SMDLX23.16-0.04
-0.17%
ClearBridge Tactical Dividend Income C
MRLRX19.08-0.05
-0.26%
BlackRock Advantage Large Cap Core R
VSVIX30.89-0.28
-0.90%
Victory Integrity Small-Cap Value Y

BHC and Stocks

Correlation & Price change

A.I.dvisor tells us that BHC and AMPH have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BHC and AMPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHC
1D Price
Change %
BHC100%
+11.05%
AMPH - BHC
29%
Poorly correlated
-1.26%
PAHC - BHC
26%
Poorly correlated
+0.33%
SWDCF - BHC
25%
Poorly correlated
N/A
VTRS - BHC
25%
Poorly correlated
-0.75%
PRGO - BHC
23%
Poorly correlated
-1.43%
More

Groups containing BHC

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHC
1D Price
Change %
BHC100%
+11.05%
Pharmaceuticals: Generic
industry (228 stocks)
9%
Poorly correlated
-1.77%